Disease Clusters?
Groups of diseases that share a large number of curated genes with each other, computed via label propagation over the shared-gene similarity graph. See also Shared-Gene Disease Pairs for pairwise comparisons.
← Back to all clusters
Cluster 284
6
Diseases
32
Unique genes
0.265
Avg. similarity score
Adult myoclonic epilepsy
Most-connected disease (5 links)
Disease
Pinned (dragged)
Node size = connections within this cluster · edge thickness = similarity strength · hover an edge for its details ·
click a node to select it and show its pairs below (double-click or Ctrl/⌘-click opens the disease page) ·
drag a node to pin it in place · scroll/pinch to zoom.
Adult myoclonic epilepsy
Familial adult myoclonic epilepsy
Benign adult familial myoclonic epilepsy
Benign myoclonic epilepsy
Early onset epilepsy with developmental delay
Myoclonic epilepsy
Member diseases (most connected first ‐ the cluster's core)
| Disease ⇵ | Connections in cluster ⇵ | Significant partners ⇵ | Curated genes ⇵ |
|---|---|---|---|
| Adult myoclonic epilepsy | 5 | 5 | 8 |
| Familial adult myoclonic epilepsy | 5 | 5 | 8 |
| Benign adult familial myoclonic epilepsy | 4 | 4 | 3 |
| Benign myoclonic epilepsy | 4 | 4 | 6 |
| Early onset epilepsy with developmental delay | 3 | 3 | 3 |
| Myoclonic epilepsy | 3 | 3 | 24 |
Top shared genes (genes linked to 2+ member diseases)
| Gene ⇵ | Member diseases ⇵ | Linked diseases |
|---|---|---|
| SAMD12 | 5 / 6 | Adult myoclonic epilepsy, Benign adult familial myoclonic epilepsy, Benign myoclonic epilepsy, Familial adult myoclonic epilepsy and 1 more |
| ADRA2B | 4 / 6 | Adult myoclonic epilepsy, Benign adult familial myoclonic epilepsy, Benign myoclonic epilepsy, Familial adult myoclonic epilepsy |
| CNTN2 | 4 / 6 | Adult myoclonic epilepsy, Benign myoclonic epilepsy, Early onset epilepsy with developmental delay, Familial adult myoclonic epilepsy |
| MARCHF6 | 3 / 6 | Adult myoclonic epilepsy, Benign myoclonic epilepsy, Familial adult myoclonic epilepsy |
| RAPGEF2 | 3 / 6 | Adult myoclonic epilepsy, Familial adult myoclonic epilepsy, Myoclonic epilepsy |
| TNRC6A | 3 / 6 | Adult myoclonic epilepsy, Familial adult myoclonic epilepsy, Myoclonic epilepsy |
| YEATS2 | 3 / 6 | Adult myoclonic epilepsy, Benign myoclonic epilepsy, Familial adult myoclonic epilepsy |
| CTNND2 | 2 / 6 | Adult myoclonic epilepsy, Benign myoclonic epilepsy |
| STARD7 | 2 / 6 | Benign adult familial myoclonic epilepsy, Familial adult myoclonic epilepsy |
What do these columns mean?
- Connections in cluster
- How many other members this disease has a shared-gene link to (the node size in the network above). The most-connected diseases are the cluster's core.
- Significant partners
- How many of those links are statistically significant (FDR q < 0.05).
- Curated genes
- Distinct curated genes linked to that disease in GeDiPNet.
- Member diseases (Top shared genes)
- How many of this cluster's diseases are linked to the gene, out of the cluster's total. Genes shared by many members are the most direct explanation of why they group together.
- Overlap genes (x / y)
- x = genes shared between this cluster and the pathway/GO term; y = that pathway/GO term's total gene count. A higher x relative to y (and to the cluster's own size) means a tighter biological match.
- Cluster gene count
- Total distinct genes across every disease in this cluster -- the "n" used in the significance test below.
- Fold enrichment
- Observed overlap divided by the overlap expected by chance, given the cluster's gene count, the pathway/term's size and the gene universe tested. 5× means five times more shared genes than random. Tells strong hits apart when q-values are all vanishingly small.
- P-value / FDR q-value
- Is this pathway/GO term's overlap with the cluster more than chance? Upper-tail hypergeometric test, Benjamini-Hochberg corrected across every tested pathway/term (prefer the q-value -- it accounts for testing many at once).
- Shared genes (Pairs within this cluster)
- Number of curated genes the two diseases in that row have in common.
- Similarity score (Pairs within this cluster)
- Jaccard-based gene overlap between the two specific diseases in that row -- same metric as the main Shared-Gene Disease Pairs page.
Enriched Pathways (why this cluster is grouped, biologically)
| Pathway ⇵ | Source ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| Neuroactive ligand-receptor interaction | KEGG | 7 / 370 | 7.1× | 4.30e-5 | 1.13e-3 ✓ sig. |
| Nicotine addiction | KEGG | 3 / 41 | 27.5× | 1.71e-4 | 3.46e-3 ✓ sig. |
| Highly calcium permeable nicotinic acetylcholine receptors | Reactome | 2 / 9 | 83.4× | 2.45e-4 | 4.58e-3 ✓ sig. |
| Androgen biosynthesis | Reactome | 2 / 11 | 68.2× | 3.73e-4 | 6.34e-3 ✓ sig. |
| Highly calcium permeable postsynaptic nicotinic acetylcholine receptors | Reactome | 2 / 12 | 62.6× | 4.46e-4 | 7.29e-3 ✓ sig. |
| GABA receptor activation | Reactome | 2 / 16 | 46.9× | 8.06e-4 | 1.16e-2 ✓ sig. |
| GABAergic synapse | KEGG | 3 / 89 | 12.7× | 1.67e-3 | 2.00e-2 ✓ sig. |
| Morphine addiction | KEGG | 3 / 91 | 12.4× | 1.78e-3 | 2.10e-2 ✓ sig. |
| Defective ACTH causes Obesity and Pro-opiomelanocortinin deficiency (POMCD) | Reactome | 1 / 2 | 188× | 5.32e-3 | 4.56e-2 ✓ sig. |
| Peptide hormone biosynthesis | Reactome | 1 / 2 | 188× | 5.32e-3 | 4.56e-2 ✓ sig. |
| Phase 0 - rapid depolarisation | Reactome | 2 / 44 | 17.1× | 6.07e-3 | 4.97e-2 ✓ sig. |
| Retrograde endocannabinoid signaling | KEGG | 3 / 149 | 7.6× | 7.13e-3 | 5.54e-2 |
| Adrenaline signalling through Alpha-2 adrenergic receptor | Reactome | 1 / 3 | 125× | 7.97e-3 | 5.96e-2 |
| Opioid Signalling | Reactome | 1 / 3 | 125× | 7.97e-3 | 5.96e-2 |
| Post-transcriptional silencing by small RNAs | Reactome | 1 / 7 | 53.6× | 1.85e-2 | 9.85e-2 |
Enriched GO Terms (Biological Process, a second line of biological evidence)
| GO term ⇵ | GO ID ⇵ | Overlap genes ⇵ | Fold enrichment ⇵ | P-value ⇵ | FDR q-value ⇵ |
|---|---|---|---|---|---|
| monoatomic ion transmembrane transport | GO:0034220 | 9 / 404 | 13.0× | 1.71e-8 | 2.72e-6 ✓ sig. |
| regulation of postsynaptic membrane potential | GO:0060078 | 5 / 59 | 49.5× | 4.98e-8 | 6.76e-6 ✓ sig. |
| monoatomic ion transport | GO:0006811 | 10 / 667 | 8.8× | 9.94e-8 | 1.20e-5 ✓ sig. |
| gamma-aminobutyric acid signaling pathway | GO:0007214 | 4 / 30 | 77.9× | 1.88e-7 | 2.06e-5 ✓ sig. |
| chloride transport | GO:0006821 | 4 / 81 | 28.8× | 1.07e-5 | 5.51e-4 ✓ sig. |
| neuromuscular synaptic transmission | GO:0007274 | 3 / 31 | 56.5× | 1.98e-5 | 8.92e-4 ✓ sig. |
| adult walking behavior | GO:0007628 | 3 / 34 | 51.5× | 2.63e-5 | 1.11e-3 ✓ sig. |
| neuronal action potential | GO:0019228 | 3 / 34 | 51.5× | 2.63e-5 | 1.11e-3 ✓ sig. |
| synaptic transmission, GABAergic | GO:0051932 | 3 / 35 | 50.1× | 2.88e-5 | 1.18e-3 ✓ sig. |
| chloride transmembrane transport | GO:1902476 | 4 / 114 | 20.5× | 4.14e-5 | 1.56e-3 ✓ sig. |
| establishment of localization in cell | GO:0051649 | 4 / 147 | 15.9× | 1.11e-4 | 3.28e-3 ✓ sig. |
| neuronal action potential propagation | GO:0019227 | 2 / 11 | 106× | 1.55e-4 | 4.19e-3 ✓ sig. |
| regulation of synaptic plasticity | GO:0048167 | 3 / 69 | 25.4× | 2.21e-4 | 5.42e-3 ✓ sig. |
| synapse organization | GO:0050808 | 3 / 72 | 24.3× | 2.51e-4 | 5.94e-3 ✓ sig. |
| regulation of membrane potential | GO:0042391 | 3 / 85 | 20.6× | 4.10e-4 | 8.35e-3 ✓ sig. |